Laurus Labs Ltd News
Growth trajectory, margins anc client additions to sustain for Laurus Labs_54960
Some of the growth is captured in the price rally, higher valuations
 "Growth trajectory, margins anc client additions to sustain for Laurus Labs_54960")
Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%_45314
The Nifty Pharma index has crossed its near-term resistance at 13,700, and may spurt another 1.5 per cent.
 "Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%_45314")
Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug_45317
Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.
 "Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug_45317")
Laurus Labs surges 6% to hit over 4-month high_42353
Analysts remain optimistic on the company's outlook for FY23 & FY24 with new capacity addition for commercial usage for FDF and API segments, ARV business and robust growth expected in CS business.
Laurus Labs up 8% in two days on purchase orders from global pharma company_30805
The company on Thursday said it has received purchase orders from a leading global life sciences company and the supplies will commence from March 2022.
 "Laurus Labs up 8% in two days on purchase orders from global pharma company_30805")
Laurus Labs bounces 16% from day's low on heavy volumes_24501
The company said its Q3FY22 results were impacted by lower sales of ARV, APIs and formulations due to stocking at channel partners and it expects improvement from January-March quarter (Q4).
Buy these mid, smallcap stocks for at least 20% returns in 2022_13585
Laurus Labs Ltd, Endurance Technologies Ltd may surge over 30 per cent whereas small cap stocks like Avanti Feeds Ltd, BASF India and Rain Industries could jump up to 40 per cent from current levels
 "Buy these mid, smallcap stocks for at least 20% returns in 2022_13585")
Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high_12610
Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI
 "Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high_12610")
